Filing Details
- Accession Number:
- 0001543407-19-000049
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-09 13:50:23
- Reporting Period:
- 2019-09-06
- Accepted Time:
- 2019-09-09 13:50:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 10795 | Becton Dickinson & Co | BDX | Surgical & Medical Instruments & Apparatus (3841) | 220760120 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1621793 | Jr E Thomas Polen | C/O Becton, Dickinson And Company 1 Becton Drive Franklin Lakes NJ 07417 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-09-06 | 13,760 | $150.12 | 30,215 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-09-06 | 7,937 | $260.26 | 22,778 | No | 4 | D | Direct | |
| Common Stock | Disposition | 2019-09-06 | 5,823 | $260.26 | 16,455 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | D | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Appreciation Rights | Disposition | 2019-09-06 | 13,760 | $0.00 | 13,760 | $150.12 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 13,763 | 2016-11-26 | 2025-11-26 | No | 4 | M | Direct |
Footnotes
- The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $260.00 through $260.61. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. This transaction was made pursuant to a 10b5-1 plan entered into on December 3, 2018.
- The stock appreciation rights vest in four annual installments beginning November 26, 2016.
Billionaire Hedge Funds
